103 related articles for article (PubMed ID: 10352612)
1. Cancer in patients aged 90 years or older: radiation therapy.
Mitsuhashi N; Hayakawa K; Yamakawa M; Sakurai H; Saito Y; Hasegawa M; Akimoto T; Hayakawa K; Niibe H
Radiology; 1999 Jun; 211(3):829-33. PubMed ID: 10352612
[TBL] [Abstract][Full Text] [Related]
2. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
3. Outcomes following reirradiation of patients with head and neck cancer.
Goldstein DP; Karnell LH; Yao M; Chamberlin GP; Nguyen TX; Funk GF
Head Neck; 2008 Jun; 30(6):765-70. PubMed ID: 18286493
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
5. Retrospective study of palliative radiotherapy in newly diagnosed head and neck carcinoma.
Stevens CM; Huang SH; Fung S; Bayley AJ; Cho JB; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; O'Sullivan B; Waldron JN; Ringash J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):958-63. PubMed ID: 20950952
[TBL] [Abstract][Full Text] [Related]
6. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant locoregional radiotherapy as best practice in patients with Merkel cell carcinoma of the head and neck.
Veness MJ; Morgan GJ; Gebski V
Head Neck; 2005 Mar; 27(3):208-16. PubMed ID: 15627249
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy for carcinomas of the head and neck in elderly patients.
Huguenin P; Sauer M; Glanzmann C; Lütolf UM
Strahlenther Onkol; 1996 Sep; 172(9):485-8. PubMed ID: 8830810
[TBL] [Abstract][Full Text] [Related]
9. Elapsed radiation therapy treatment time as a predictor of survival in patients with advanced head and neck cancer who receive chemotherapy and radiation therapy.
Alden ME; O'Reilly RC; Topham A; Lowry LD; Brodovsky H; Curran WJ
Radiology; 1996 Dec; 201(3):675-80. PubMed ID: 8939214
[TBL] [Abstract][Full Text] [Related]
10. Treatment of localized non-Hodgkin's lymphomas of the head and neck: focusing on cases of non-lethal midline granuloma.
Sakata K; Hareyama M; Oouchi A; Sido M; Nagakura H; Morita K; Harabuchi Y; Kataura A; Hinoda Y
Radiat Oncol Investig; 1998; 6(4):161-9. PubMed ID: 9727875
[TBL] [Abstract][Full Text] [Related]
11. Results of radiotherapy in stage I to II extranodal non-Hodgkin's lymphoma of the head and neck.
Kuten A; Ben-Shahar M; Epelbaum R; Haim N; Cohen Y; Robinson E
Strahlenther Onkol; 1989 Aug; 165(8):578-83. PubMed ID: 2772814
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
13. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice.
Veness MJ; Morgan GJ; Palme CE; Gebski V
Laryngoscope; 2005 May; 115(5):870-5. PubMed ID: 15867656
[TBL] [Abstract][Full Text] [Related]
14. Acute toxicity of curative radiotherapy in elderly patients.
Huguenin P; Glanzmann C; Lütolf UM
Strahlenther Onkol; 1996 Dec; 172(12):658-63. PubMed ID: 8972750
[TBL] [Abstract][Full Text] [Related]
15. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
[TBL] [Abstract][Full Text] [Related]
16. Impact of pretreatment body mass index on patients with head-and-neck cancer treated with radiation.
Pai PC; Chuang CC; Tseng CK; Tsang NM; Chang KP; Yen TC; Liao CT; Hong JH; Chang JT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e93-e100. PubMed ID: 22342298
[TBL] [Abstract][Full Text] [Related]
17. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
Hoskin PJ; Robinson M; Slevin N; Morgan D; Harrington K; Gaffney C
J Clin Oncol; 2009 Dec; 27(34):5751-6. PubMed ID: 19884550
[TBL] [Abstract][Full Text] [Related]
18. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
[TBL] [Abstract][Full Text] [Related]
19. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
[TBL] [Abstract][Full Text] [Related]
20. Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity.
Hoebers F; Heemsbergen W; Moor S; Lopez M; Klop M; Tesselaar M; Rasch C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e111-8. PubMed ID: 21362581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]